Please enable JavaScript to continue using this application.

Compare $MEDP vs $WST | Chartloom

Compare

$MEDP vs $WST

Medpace Holdings Inc · West Pharmaceutical Services Inc

MEDP

Medpace Holdings Inc

WST

West Pharmaceutical Services Inc

Compare $MEDP vs $WST

Comparing Medpace Holdings Inc and West Pharmaceutical Services Inc

MEDPMedpace Holdings Inc

WSTWest Pharmaceutical Services Inc

MEDPMedpace Holdings Inc

Market cap

$17.08B

P/E (TTM)

35.56x

Forward P/E (NTM)

32.69x

Forward P/S (NTM)

5.76x

Rev growth (TTM)

24.7%

YTD performance

7.2%

52W performance

15.3%

FCF yield

4.1%

WSTWest Pharmaceutical Services Inc

Market cap

$25.76B

P/E (TTM)

46.20x

Forward P/E (NTM)

39.00x

Forward P/S (NTM)

7.45x

Rev growth (TTM)

12.4%

YTD performance

32.4%

52W performance

36.6%

FCF yield

1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MEDP

WST

Detailed metrics comparison

MEDP

Medpace Holdings Inc

WST

West Pharmaceutical Services Inc

Market Cap

MEDP$17.08B

WST$25.76B

Enterprise Value

MEDP$16.58B

WST$25.53B

Price

MEDP$612.05

WST$366.00

P/E Ratio

MEDP35.56x

WST46.20x

P/S Ratio

MEDP6.14x

WST7.74x

EV/Sales

MEDP5.96x

WST7.67x

EV/EBITDA

MEDP27.13x

WST28.16x

P/B Ratio

MEDP38.57x

WST8.84x

P/FCF Ratio

MEDP24.17x

WST58.96x

EV/FCF

MEDP23.46x

WST58.44x

PEG Ratio

MEDP2.97x

WST3.05x

Forward P/E (NTM)

MEDP32.69x

WST39.00x

Forward P/S (NTM)

MEDP5.76x

WST7.45x

Revenue (TTM)

MEDP$2.78B

WST$3.33B

Revenue Growth (YoY)

MEDP24.7%

WST12.4%

Forward Rev Growth

MEDP6.2%

WST6.2%

Gross Margin (TTM)

MEDP28.8%

WST36.8%

Operating Margin (TTM)

MEDP21.0%

WST20.4%

EBITDA Margin (TTM)

MEDP22.0%

WST27.0%

Net Margin (TTM)

MEDP17.7%

WST17.0%

FCF Margin (TTM)

MEDP25.4%

WST13.1%

Net Income (TTM)

MEDP$492M

WST$565M

FCF (TTM)

MEDP$707M

WST$437M

EPS (TTM)

MEDP$17.21

WST$7.92

ROE (TTM)

MEDP110.1%

WST18.5%

ROA (TTM)

MEDP24.8%

WST13.6%

ROIC (TTM)

MEDP110.1%

WST17.3%

Cash

MEDP$503M

WST$436M

Debt

MEDP$0

WST$207M

Net Cash/Debt

MEDP$503M

WST$229M

Current Ratio (TTM)

MEDP0.73x

WST2.82x

Quick Ratio (TTM)

MEDP0.66x

WST2.12x

Debt/Equity (TTM)

MEDP0.00x

WST0.07x

Debt/Assets (TTM)

MEDP0.0%

WST0.0%

Interest Coverage (TTM)

MEDPN/A

WSTN/A

Net Debt/EBITDA (TTM)

MEDP0.00x

WST0.00x

Beta

MEDP1.11

WST1.15

52W Performance

MEDP15.3%

WST36.6%

YTD Performance

MEDP7.2%

WST32.4%

% from 52W High

MEDP-9.7%

WST-5.2%

% from 52W Low

MEDP64.1%

WST63.5%

Asset Turnover (TTM)

MEDP1.41x

WST0.80x

FCF Yield (TTM)

MEDP4.1%

WST1.7%

Earnings Yield (TTM)

MEDP2.9%

WST2.2%

Dividend Yield (TTM)

MEDPN/A

WST0.2%

Rule of 40

MEDP50.1

WST25.5

EV/GP/RG

MEDP3.15

WST5.32

Ticker research

View MEDP research View WST research

Metric	MEDP Medpace Holdings Inc	WST West Pharmaceutical Services Inc
Market & Valuation
Market Cap	$17.08B	$25.76B
Enterprise Value	$16.58B	$25.53B
Price	$612.05	$366.00
P/E Ratio	35.56x	46.20x
P/S Ratio	6.14x	7.74x
EV/Sales	5.96x	7.67x
EV/EBITDA	27.13x	28.16x
P/B Ratio	38.57x	8.84x
P/FCF Ratio	24.17x	58.96x
EV/FCF	23.46x	58.44x
PEG Ratio	2.97x	3.05x
Forward P/E (NTM)	32.69x	39.00x
Forward P/S (NTM)	5.76x	7.45x
Revenue & Growth
Revenue (TTM)	$2.78B	$3.33B
Revenue Growth (YoY)	24.7%	12.4%
Forward Rev Growth	6.2%	6.2%
Profitability
Gross Margin (TTM)	28.8%	36.8%
Operating Margin (TTM)	21.0%	20.4%
EBITDA Margin (TTM)	22.0%	27.0%
Net Margin (TTM)	17.7%	17.0%
FCF Margin (TTM)	25.4%	13.1%
Net Income (TTM)	$492M	$565M
FCF (TTM)	$707M	$437M
EPS (TTM)	$17.21	$7.92
ROE (TTM)	110.1%	18.5%
ROA (TTM)	24.8%	13.6%
ROIC (TTM)	110.1%	17.3%
Financial Health
Cash	$503M	$436M
Debt	$0	$207M
Net Cash/Debt	$503M	$229M
Current Ratio (TTM)	0.73x	2.82x
Quick Ratio (TTM)	0.66x	2.12x
Debt/Equity (TTM)	0.00x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.11	1.15
52W Performance	15.3%	36.6%
YTD Performance	7.2%	32.4%
% from 52W High	-9.7%	-5.2%
% from 52W Low	64.1%	63.5%
Efficiency & Yields
Asset Turnover (TTM)	1.41x	0.80x
FCF Yield (TTM)	4.1%	1.7%
Earnings Yield (TTM)	2.9%	2.2%
Dividend Yield (TTM)	N/A	0.2%
Other
Rule of 40	50.1	25.5
EV/GP/RG	3.15	5.32
Ticker research	View MEDP research	View WST research

Valuation

P/E Ratio

MEDP

35.56x

WST

46.20x

P/S Ratio

MEDP

6.14x

WST

7.74x

EV/FCF

MEDP

23.46x

WST

58.44x

Growth & revenue

Revenue Growth TTM

MEDP

24.7%

WST

12.4%

Forward Revenue Growth

WST

6.2%

MEDP

6.2%

Profitability & performance

Gross Margin

WST

36.8%

MEDP

28.8%

ROE

MEDP

110.1%

WST

18.5%

FCF Yield %

MEDP

4.1%

WST

1.7%

52-Week Performance

WST

36.6%

MEDP

15.3%

Detailed metrics comparison

MEDP

Medpace Holdings Inc

WST

West Pharmaceutical Services Inc

Market Cap

MEDP$17.08B

WST$25.76B

Enterprise Value

MEDP$16.58B

WST$25.53B

Price

MEDP$612.05

WST$366.00

P/E Ratio

MEDP35.56x

WST46.20x

P/S Ratio

MEDP6.14x

WST7.74x

EV/Sales

MEDP5.96x

WST7.67x

EV/EBITDA

MEDP27.13x

WST28.16x

P/B Ratio

MEDP38.57x

WST8.84x

P/FCF Ratio

MEDP24.17x

WST58.96x

EV/FCF

MEDP23.46x

WST58.44x

PEG Ratio

MEDP2.97x

WST3.05x

Forward P/E (NTM)

MEDP32.69x

WST39.00x

Forward P/S (NTM)

MEDP5.76x

WST7.45x

Revenue (TTM)

MEDP$2.78B

WST$3.33B

Revenue Growth (YoY)

MEDP24.7%

WST12.4%

Forward Rev Growth

MEDP6.2%

WST6.2%

Gross Margin (TTM)

MEDP28.8%

WST36.8%

Operating Margin (TTM)

MEDP21.0%

WST20.4%

EBITDA Margin (TTM)

MEDP22.0%

WST27.0%

Net Margin (TTM)

MEDP17.7%

WST17.0%

FCF Margin (TTM)

MEDP25.4%

WST13.1%

Net Income (TTM)

MEDP$492M

WST$565M

FCF (TTM)

MEDP$707M

WST$437M

EPS (TTM)

MEDP$17.21

WST$7.92

ROE (TTM)

MEDP110.1%

WST18.5%

ROA (TTM)

MEDP24.8%

WST13.6%

ROIC (TTM)

MEDP110.1%

WST17.3%

Cash

MEDP$503M

WST$436M

Debt

MEDP$0

WST$207M

Net Cash/Debt

MEDP$503M

WST$229M

Current Ratio (TTM)

MEDP0.73x

WST2.82x

Quick Ratio (TTM)

MEDP0.66x

WST2.12x

Debt/Equity (TTM)

MEDP0.00x

WST0.07x

Debt/Assets (TTM)

MEDP0.0%

WST0.0%

Interest Coverage (TTM)

MEDPN/A

WSTN/A

Net Debt/EBITDA (TTM)

MEDP0.00x

WST0.00x

Beta

MEDP1.11

WST1.15

52W Performance

MEDP15.3%

WST36.6%

YTD Performance

MEDP7.2%

WST32.4%

% from 52W High

MEDP-9.7%

WST-5.2%

% from 52W Low

MEDP64.1%

WST63.5%

Asset Turnover (TTM)

MEDP1.41x

WST0.80x

FCF Yield (TTM)

MEDP4.1%

WST1.7%

Earnings Yield (TTM)

MEDP2.9%

WST2.2%

Dividend Yield (TTM)

MEDPN/A

WST0.2%

Rule of 40

MEDP50.1

WST25.5

EV/GP/RG

MEDP3.15

WST5.32

Ticker research

View MEDP research View WST research

Metric	MEDP Medpace Holdings Inc	WST West Pharmaceutical Services Inc
Market & Valuation
Market Cap	$17.08B	$25.76B
Enterprise Value	$16.58B	$25.53B
Price	$612.05	$366.00
P/E Ratio	35.56x	46.20x
P/S Ratio	6.14x	7.74x
EV/Sales	5.96x	7.67x
EV/EBITDA	27.13x	28.16x
P/B Ratio	38.57x	8.84x
P/FCF Ratio	24.17x	58.96x
EV/FCF	23.46x	58.44x
PEG Ratio	2.97x	3.05x
Forward P/E (NTM)	32.69x	39.00x
Forward P/S (NTM)	5.76x	7.45x
Revenue & Growth
Revenue (TTM)	$2.78B	$3.33B
Revenue Growth (YoY)	24.7%	12.4%
Forward Rev Growth	6.2%	6.2%
Profitability
Gross Margin (TTM)	28.8%	36.8%
Operating Margin (TTM)	21.0%	20.4%
EBITDA Margin (TTM)	22.0%	27.0%
Net Margin (TTM)	17.7%	17.0%
FCF Margin (TTM)	25.4%	13.1%
Net Income (TTM)	$492M	$565M
FCF (TTM)	$707M	$437M
EPS (TTM)	$17.21	$7.92
ROE (TTM)	110.1%	18.5%
ROA (TTM)	24.8%	13.6%
ROIC (TTM)	110.1%	17.3%
Financial Health
Cash	$503M	$436M
Debt	$0	$207M
Net Cash/Debt	$503M	$229M
Current Ratio (TTM)	0.73x	2.82x
Quick Ratio (TTM)	0.66x	2.12x
Debt/Equity (TTM)	0.00x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.11	1.15
52W Performance	15.3%	36.6%
YTD Performance	7.2%	32.4%
% from 52W High	-9.7%	-5.2%
% from 52W Low	64.1%	63.5%
Efficiency & Yields
Asset Turnover (TTM)	1.41x	0.80x
FCF Yield (TTM)	4.1%	1.7%
Earnings Yield (TTM)	2.9%	2.2%
Dividend Yield (TTM)	N/A	0.2%
Other
Rule of 40	50.1	25.5
EV/GP/RG	3.15	5.32
Ticker research	View MEDP research	View WST research